The Oncosearch | Oncotarget

Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells Research Paper

Harish Chandra Pal, Ronald D. Baxter, Katherine M. Hunt, Jyoti Agarwal, Craig A. Elmets, Mohammad Athar, Farrukh Afaq

Published Jul 31, 2015 · Vol. 6, No. 29 · pp. 28296-28311

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression Research Paper

Victor Ho, Tong Seng Lim, Justin Lee, Jeffrey Steinberg, Radoslaw Szmyd, Muly Tham, Jadegoud Yaligar, Philipp Kaldis, Jean-Pierre Abastado, Valerie Chew

Published Jul 23, 2015 · Vol. 6, No. 29 · pp. 27252-27266

AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma Research Paper

Yiran Li, Yuanhui Jia, Qi Che, Qian Zhou, Kai Wang, Xiao-Ping Wan

Published Jul 20, 2015 · Vol. 6, No. 28 · pp. 26373-26387

CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration Research Paper

Yanqing Gong, Wei Qiu, Xianghui Ning, Xinyu Yang, Libo Liu, Zicheng Wang, Jian Lin, Xuesong Li, Yinglu Guo

Published Jul 16, 2015 · Vol. 6, No. 28 · pp. 25856-25867

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma Research Paper

Luigi Fattore, Debora Malpicci, Emanuele Marra, Francesca Belleudi, Alessia Noto, Claudia De Vitis, Maria Elena Pisanu, Pierpaolo Coluccia, Rosa Camerlingo, Giuseppe Roscilli, Antoni Ribas, Arianna Di Napoli, Maria Rosaria Torrisi, Luigi Aurisicchio, Paolo Antonio Ascierto, Rita Mancini, Gennaro Ciliberto

Published Jul 7, 2015 · Vol. 6, No. 28 · pp. 24823-24841

Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326 Research Paper

Jing Ke, Yi-long Yao, Jian Zheng, Ping Wang, Yun-hui Liu, Jun Ma, Zhen Li, Xiao-bai Liu, Zhi-qing Li, Zhen-hua Wang, Yi-xue Xue

Published Jun 27, 2015 · Vol. 6, No. 26 · pp. 21934-21949

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells Priority Research Paper

Irene Ischenko, Oleksi Petrenko, Michael J. Hayman

Published Jun 19, 2015 · Vol. 6, No. 18 · pp. 15814-15827

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation Research Paper

Marta Lionetti, Marzia Barbieri, Katia Todoerti, Luca Agnelli, Simona Marzorati, Sonia Fabris, Gabriella Ciceri, Serena Galletti, Giulia Milesi, Martina Manzoni, Mara Mazzoni, Angela Greco, Giovanni Tonon, Pellegrino Musto, Luca Baldini, Antonino Neri

Published Jun 10, 2015 · Vol. 6, No. 27 · pp. 24205-24217

Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials Clinical Research Papers

Ruiqin Mai, Songxia Zhou, Weixiang Zhong, Siming Rong, Zhichao Cong, Yunxian Li, Qizhi Xie, Huanming Chen, Xiaoyun Li, Shuhui Liu, Yabin Cheng, Yuanshen Huang, Youwen Zhou, Guohong Zhang

Published Jun 8, 2015 · Vol. 6, No. 29 · pp. 28502-28512

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 Research Paper

Zoran Gatalica, Nurija Bilalovic, Juan P. Palazzo, Ryan P. Bender, Jeffrey Swensen, Sherri Z. Millis, Semir Vranic, Daniel Von Hoff, Robert J. Arceci

Published Jun 8, 2015 · Vol. 6, No. 23 · pp. 19819-19825

Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells Research Paper

Stefan Eder, Andreas Lamkowski, Markus Priller, Matthias Port, Konrad Steinestel

Published May 22, 2015 · Vol. 6, No. 19 · pp. 17178-17191

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors Research Paper

Audrey Delmas, Julia Cherier, Magdalena Pohorecka, Claire Medale-Giamarchi, Nicolas Meyer, Anne Casanova, Olivier Sordet, Laurence Lamant, Ariel Savina, Anne Pradines, Gilles Favre

Published May 7, 2015 · Vol. 6, No. 17 · pp. 15250-15264

Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells Research Paper

Chengguang Zhao, Hui Xiao, Xiaojuan Wu, Chenglong Li, Guang Liang, Shulin Yang, Jiayuh Lin

Published May 4, 2015 · Vol. 6, No. 16 · pp. 14472-14487

Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway Research Paper

Nguyen Dinh Thang, Ichiro Yajima, Mayuko Y. Kumasaka, Machiko Iida, Tamio Suzuki, Masashi Kato

Published Apr 20, 2015 · Vol. 6, No. 16 · pp. 14290-14299

Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion Research Paper

Wen-Liang Chen, Andrew Barszczyk, Ekaterina Turlova, Marielle Deurloo, Baosong Liu, Burton B. Yang, James T. Rutka, Zhong-Ping Feng, Hong-Shuo Sun

Published Apr 19, 2015 · Vol. 6, No. 18 · pp. 16321-16340

Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter Research Paper

Jian-Ge Qiu, Yao-Jun Zhang, Yong Li, Jin-Ming Zhao, Wen-Ji Zhang, Qi-Wei Jiang, Xiao-Long Mei, You-Qiu Xue, Wu-Ming Qin, Yang Yang, Di-Wei Zheng, Yao Chen, Meng-Ning Wei, Zhi Shi

Published Apr 14, 2015 · Vol. 6, No. 17 · pp. 15494-15509

Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition Research Paper

Jia-Ji Lin, Tian-Zhi Zhao, Wen-Ke Cai, Yong-Xiang Yang, Chao Sun, Zhuo Zhang, Yu-Qiao Xu, Ting Chang, Zhu-Yi Li

Published Apr 10, 2015 · Vol. 6, No. 19 · pp. 17107-17120

Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis Research Paper

Donna M. Brennan-Crispi, Claudia Hossain, Joya Sahu, Mary Brady, Natalia A. Riobo, Má»¹ G. Mahoney

Published Mar 24, 2015 · Vol. 6, No. 11 · pp. 8593-8605

Ïˆ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling Research Paper

Jin Ding, Wen Wen, Daimin Xiang, Peipei Yin, Yanfang Liu, Chang Liu, Guoping He, Zhuo Cheng, Jianpeng Yin, Chunquan Sheng, Wen Zhang, Fajun Nan, Wencai Ye, Xiuli Zhang, Hongyang Wang

Published Mar 23, 2015 · Vol. 6, No. 13 · pp. 11627-11639

Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway Research Paper

Jui-Chieh Chen, Yu-Ju Chen, Chih-Yang Lin, Yi-Chin Fong, Chin-Jung Hsu, Chun-Hao Tsai, Jen-Liang Su, Chih-Hsin Tang

Published Mar 18, 2015 · Vol. 6, No. 13 · pp. 11434-11446

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells Research Paper

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression Research Paper

AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma Research Paper

CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration Research Paper

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma Research Paper

Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326 Research Paper

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells Priority Research Paper

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation Research Paper

Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials Clinical Research Papers

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 Research Paper

Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells Research Paper

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors Research Paper

Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells Research Paper

Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway Research Paper

Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion Research Paper

Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter Research Paper

Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition Research Paper

Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis Research Paper

Ïˆ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling Research Paper

Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells Research Paper

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression Research Paper

AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma Research Paper

CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration Research Paper

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma Research Paper

Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326 Research Paper

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells Priority Research Paper

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation Research Paper

Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials Clinical Research Papers

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 Research Paper

Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells Research Paper

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors Research Paper

Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells Research Paper

Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway Research Paper

Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion Research Paper

Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter Research Paper

Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition Research Paper

Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis Research Paper

Ïˆ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling Research Paper

Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway Research Paper